183 related articles for article (PubMed ID: 29606869)
21. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
22. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
Zhao FH; Chen YD; Jin ZN; Lu SZ
Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
[TBL] [Abstract][Full Text] [Related]
23. Promoting vascular healing using nanofibrous ticagrelor-eluting stents.
Lee CH; Hsieh MJ; Liu KS; Cheng CW; Chang SH; Liu SJ; Wang CJ; Hsu MY; Hung KC; Yeh YH; Chen WJ; Hsieh IC; Juang JH; Wen MS
Int J Nanomedicine; 2018; 13():6039-6048. PubMed ID: 30323591
[TBL] [Abstract][Full Text] [Related]
24. Activation of Protein Kinase G (PKG) Reduces Neointimal Hyperplasia, Inhibits Platelet Aggregation, and Facilitates Re-endothelialization.
Kim JY; Yang HM; Lee JE; Kim BK; Jin S; Lee J; Park KW; Cho HJ; Kwon YW; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
Sci Rep; 2016 Nov; 6():36979. PubMed ID: 27833146
[TBL] [Abstract][Full Text] [Related]
25. Prevention of neointimal formation using miRNA-126-containing nanoparticle-conjugated stents in a rabbit model.
Izuhara M; Kuwabara Y; Saito N; Yamamoto E; Hakuno D; Nakashima Y; Horie T; Baba O; Nishiga M; Nakao T; Nishino T; Nakazeki F; Ide Y; Kimura M; Kimura T; Ono K
PLoS One; 2017; 12(3):e0172798. PubMed ID: 28253326
[TBL] [Abstract][Full Text] [Related]
26. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
[TBL] [Abstract][Full Text] [Related]
27. A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammation.
Ali MT; Martin K; Kumar AH; Cavallin E; Pierrou S; Gleeson BM; McPheat WL; Turner EC; Huang CL; Khider W; Vaughan C; Caplice NM
Biomaterials; 2015 Nov; 69():22-9. PubMed ID: 26275859
[TBL] [Abstract][Full Text] [Related]
28. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
[TBL] [Abstract][Full Text] [Related]
29. Arsenic Trioxide-Coated Stent Is an Endothelium-Friendly Drug Eluting Stent.
Zhao Y; Du R; Zhou T; Yang D; Huang Y; Wang Y; Huang J; Ma X; He F; Qiu J; Wang G
Adv Healthc Mater; 2018 Aug; 7(15):e1800207. PubMed ID: 29770610
[TBL] [Abstract][Full Text] [Related]
30. Pro-Healing Nanomatrix-Coated Stent Analysis in an
Zhang X; Chen J; Brott BC; Anderson PG; Hwang PTJ; Sherwood J; Huskin G; Yoon YS; Virmani R; Jun HW
ACS Appl Mater Interfaces; 2022 Nov; 14(46):51728-51743. PubMed ID: 36346768
[TBL] [Abstract][Full Text] [Related]
31. Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug.
Carlyle WC; McClain JB; Tzafriri AR; Bailey L; Zani BG; Markham PM; Stanley JR; Edelman ER
J Control Release; 2012 Sep; 162(3):561-7. PubMed ID: 22800575
[TBL] [Abstract][Full Text] [Related]
32. Enhanced endothelialization of a new stent polymer through surface enhancement and incorporation of growth factor-delivering microparticles.
Xu H; Nguyen KT; Brilakis ES; Yang J; Fuh E; Banerjee S
J Cardiovasc Transl Res; 2012 Aug; 5(4):519-27. PubMed ID: 22639344
[TBL] [Abstract][Full Text] [Related]
33. Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor.
Ma X; Hibbert B; Dhaliwal B; Seibert T; Chen YX; Zhao X; O'Brien ER
Cardiovasc Res; 2010 May; 86(2):338-45. PubMed ID: 20167573
[TBL] [Abstract][Full Text] [Related]
34. Candidates for smart cardiovascular medical device coatings: A comparative study with endothelial and smooth muscle cells.
Ceresnakova M; Murray D; Soulimane T; Hudson SP
Eur J Pharmacol; 2021 Nov; 910():174490. PubMed ID: 34492283
[TBL] [Abstract][Full Text] [Related]
35. Study of functional drug-eluting stent in promoting endothelialization and antiproliferation.
Hou R; Wu L; Zhu Y; Wang J; Yang Z; Tu Q; Huang N
J Biomater Sci Polym Ed; 2020 Feb; 31(2):244-260. PubMed ID: 31626738
[TBL] [Abstract][Full Text] [Related]
36. Activation of transient receptor potential vanilloid 1 accelerates re-endothelialization and inhibits neointimal formation after vascular injury.
Su L; Zhang Y; He K; Wei S; Pei H; Wang Q; Yang D; Yang Y
J Vasc Surg; 2017 Jan; 65(1):197-205.e2. PubMed ID: 26947234
[TBL] [Abstract][Full Text] [Related]
37. Local insulin application on the carotid artery inhibits neointima formation.
Chiang S; Breen DM; Guo J; Mori Y; Giacca A
Can J Physiol Pharmacol; 2013 Dec; 91(12):1086-94. PubMed ID: 24289080
[TBL] [Abstract][Full Text] [Related]
38. Development of a biodegradable sirolimus-eluting stent coated by ultrasonic atomizing spray.
Kim SJ; Park JG; Kim JH; Heo JS; Choi JW; Jang YS; Yoon J; Lee SJ; Kwon IK
J Nanosci Nanotechnol; 2011 Jul; 11(7):5689-97. PubMed ID: 22121592
[TBL] [Abstract][Full Text] [Related]
39. Secreted Matrix Metalloproteinase-9 of Proliferating Smooth Muscle Cells as a Trigger for Drug Release from Stent Surface Polymers in Coronary Arteries.
Gliesche DG; Hussner J; Witzigmann D; Porta F; Glatter T; Schmidt A; Huwyler J; Meyer Zu Schwabedissen HE
Mol Pharm; 2016 Jul; 13(7):2290-300. PubMed ID: 27241028
[TBL] [Abstract][Full Text] [Related]
40. Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model.
Sharif F; Hynes SO; McCullagh KJ; Ganley S; Greiser U; McHugh P; Crowley J; Barry F; O'Brien T
Gene Ther; 2012 Mar; 19(3):321-8. PubMed ID: 21716298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
